Vitamin K deficiency leads to exacerbation of murine dextran sulfate sodium-induced colitis

Journal of Gastroenterology

Volumn 51, Issue 4, 2016, Pages 346-356

  Shiraishi, Eri ^a   Iijima, Hideki ^a   Shinzaki, Shinichiro ^a   Nakajima, Sachiko ^b   Inoue, Takahiro ^a   Hiyama, Satoshi ^a   Kawai, Shoichiro ^a   Araki, Manabu ^a   Yamaguchi, Toshio ^a   Hayashi, Yoshito ^a   Fujii, Hironobu ^a   Nishida, Tsutomu ^b   Tsujii, Masahiko ^a   Takehara, Tetsuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOYONAKA MUNICIPAL HOSPITAL   (Japan)

Author keywords

B cells; IL 6; Inflammatory bowel disease; Vitamin K

Indexed keywords

CASPASE 3; CASPASE 7; CD11B ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; DEXTRAN SULFATE; INTERLEUKIN 6; LIPOCORTIN 5; MENATETRENONE; VITAMIN K GROUP; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LAMINA PROPRIA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; DOWN REGULATION; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ANIMALS; APOPTOSIS; COLITIS; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; VITAMIN K DEFICIENCY;

EID: 84940056235     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-015-1112-x     Document Type: Article

References (46)

1. Hamilton MJ, Snapper SB, Blumberg RS. Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance. J Gastroenterol. 2012;47:1–8.
2. Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol. 2013;48:315–21.
3. Agrawal M, Arora S, Li J, et al. Bone, inflammation, and inflammatory bowel disease. Curr Osteoporos Rep. 2011;9:251–7.
4. Cockayne S, Adamson J, Lanham-New S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:1256–61.
5. Schoon EJ, Muller MC, Vermeer C, et al. Low serum and bone vitamin K status in patients with longstanding Crohn’s disease: another pathogenetic factor of osteoporosis in Crohn’s disease? Gut. 2001;48:473–7.
6. Kuwabara A, Tanaka K, Tsugawa N, et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int. 2009;20:935–42.
7. Nowak JK, Grzybowska-Chlebowczyk U, Landowski P, et al. Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease. Sci Rep. 2014;4:4768.
8. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood. 1999;93:1798–808.
9. Ronden JE, Thijssen HH, Vermeer C. Tissue distribution of K-vitamers under different nutritional regimens in the rat. Biochim Biophys Acta. 1998;1379:16–22.
10. Huber AM, Davidson KW, O’Brien-Morse ME, et al. Tissue phylloquinone and menaquinones in rats are affected by age and gender. J Nutr. 1999;129:1039–44.
11. Berkner KL. The vitamin K-dependent carboxylase. Annu Rev Nutr. 2005;25:127–49.
12. Nimptsch K, Hailer S, Rohrmann S, et al. Determinants and correlates of serum undercarboxylated osteocalcin. Ann Nutr Metab. 2007;51:563–70.
13. Szulc P, Meunier PJ. Is vitamin K deficiency a risk factor for osteoporosis in Crohn’s disease? Lancet. 2001;357:1995–6.
14. Vermeer C, Shearer MJ, Zittermann A, et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr. 2004;43:325–35.
15. Nakajima S, Iijima H, Egawa S, et al. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease. Nutrition. 2011;27:1023–8.
16. Ohsaki Y, Shirakawa H, Hiwatashi K, et al. Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat. Biosci Biotechnol Biochem. 2006;70:926–32.
17. Reddi K, Henderson B, Meghji S, et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine. 1995;7:287–90.
18. Shea MK, Booth SL, Massaro JM, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2008;167:313–20.
19. Vereecke L, Sze M, Mc Guire C, et al. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J Exp Med. 2010;207:1513–23.
20. Dohi T, Ejima C, Kato R, et al. Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology. 2005;128:411–23.
21. Iijima H, Neurath MF, Nagaishi T, et al. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1. J Exp Med. 2004;199:471–82.
22. Mukai A, Iijima H, Hiyama S, et al. Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn’s disease. J Gastroenterol. 2014;49:1524–35.
23. Sakaguchi S. Regulatory T cells: history and perspective. Methods Mol Biol. 2011;707:3–17.
24. Nishimaki J, Miyazawa K, Yaguchi M, et al. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation. Leukemia. 1999;13:1399–405.
25. Sakagami H, Satoh K, Hakeda Y, et al. Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol. 2000;46:129–43 (Noisy-le-grand).
26. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000;30:298–307.
27. Conly JM, Stein K, Worobetz L, et al. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol. 1994;89:915–23.
28. Beulens JW, Booth SL, van den Heuvel EG, et al. The role of menaquinones [vitamin K(2)] in human health. Br J Nutr. 2013;110:1357–68.
29. Ebina K, Shi K, Hirao M, et al. Vitamin K2 administration is associated with decreased disease activity in patients with rheumatoid arthritis. Mod Rheumatol. 2013;23:1001–7.
30. Okamoto H, Shidara K, Hoshi D, et al. Anti-arthritis effects of vitamin K(2) (menaquinone-4)—a new potential therapeutic strategy for rheumatoid arthritis. FEBS J. 2007;274:4588–94.
31. Suzuki A, Hanada T, Mitsuyama K, et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med. 2001;193:471–81.
32. Terabe F, Fujimoto M, Serada S, et al. Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4(+) T-cell responses in murine colitis. Inflamm Bowel Dis. 2011;17:491–502.
33. Yaguchi M, Miyazawa K, Katagiri T, et al. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid. Leukemia. 1997;11:779–87.
34. Nishikawa Y, Carr BI, Wang M, et al. Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem. 1995;270:28304–10.
35. Hatanaka H, Ishizawa H, Nakamura Y, et al. Effects of vitamin K3 and K5 on proliferation, cytokine production, and regulatory T cell-frequency in human peripheral-blood mononuclear cells. Life Sci. 2014;99:61–8.
36. Karasawa S, Azuma M, Kasama T, et al. Vitamin K2 covalently binds to Bak and induces Bak-mediated apoptosis. Mol Pharmacol. 2013;83:613–20.
37. Ozaki I, Zhang H, Mizuta T, et al. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res. 2007;13:2236–45.
38. Hurtado B, de Frutos PG. GAS6 in systemic inflammatory diseases: with and without infection. Crit Care. 2010;14:1003.
39. Rothlin CV, Lemke G. TAM receptor signaling and autoimmune disease. Curr Opin Immunol. 2010;22:740–6.
40. Asselin-Paturel C, Brizard G, Chemin K, et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med. 2005;201:1157–67.
41. Gautier G, Humbert M, Deauvieau F, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med. 2005;201:1435–46.
42. Rothlin CV, Ghosh S, Zuniga EI, et al. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007;131:1124–36.
43. Yokoyama T, Miyazawa K, Naito M, et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy. 2008;4:629–40.
44. Shinzaki S, Iijima H, Fujii H, et al. Altered oligosaccharide structures reduce colitis induction in mice defective in beta-1,4-galactosyltransferase. Gastroenterology. 2012;142:1172–82.
45. Koivu-Tikkanen TJ, Schurgers LJ, Thijssen HH, et al. Intestinal, hepatic, and circulating vitamin K levels at low and high intakes of vitamin K in rats. Br J Nutr. 2000;83:185–90.
46. Hollander D, Rim E, Ruble PE Jr. Vitamin K2 colonic and ileal in vivo absorption: bile, fatty acids, and pH effects on transport. Am J Physiol. 1977;233:E124–9.